-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - current evidence of low strength suggests the potential for benefit and little evidence of increased harm … Current evidence of low strength suggests the potential for benefit and little evidence of increased harm
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - current evidence of low strength suggests the potential for benefit and little evidence of increased harm … Current evidence of low strength suggests the potential for benefit and little evidence of increased harm
-
effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
August 01, 2009 - AHRQ Slide Template 2009
Presentation of Findings
Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Methods Guide for Effectiveness and Comparative Effectiveness Reviews
Presentation of Findings
Systematic Review Process Overview
Systematic Review Process Overview
This slide illustrates th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Layout 1
Background
Juvenile idiopathic arthritis (JIA) is the
most common rheumatologic disease in
childhood, with an overall prevalence of 7
to 400 per 100,000 children. JIA is an
important cause of chronic disease in
childhood, with prevalence similar to type I
diabetes mellitus. Several classification
systems ha…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - inhibiting
drugs in migraine prophylaxis, the conclusions of the
AHRQ report regarding benefit‐ to‐harm
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction-user-guide-to-ocer_130129.pdf
April 26, 2012 - 1
Introduction to Developing a Protocol for Observational
Comparative Effectiveness Research: A User’s Guide
Scott R. Smith, Ph.D.
Agency for Healthcare Research and Quality, Rockville, MD
Background
When making health care decisions, patients, health
care providers, and policymakers routinely seek
unbiased inf…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
July 28, 2016 - effect estimates, as well as on
estimates of the absolute effect (including number needed to treat or harm … judgment about the
degree to which a new quantitative synthesis would change conclusions about benefit
harm … progression in a large population would give insight into the
existing degree of certainty about the benefit-harm
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
November 24, 2014 - Source: www.effectivehealthcare.ahrq.gov
Published online: November 24, 2014
Evidence-based Practice Center Systematic Review Protocol
Project Title: Nonpharmacological Versus Pharmacological Treatments for Adult
Patients With Major Depressive Disorder
Initial Publication Date if applicable: June 19, 2014
Ame…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - high-cholesterol-medicines-update-protocol-130516
Evidence-based Practice Center Systematic Review Protocol
Project Title: Update of Comparative Effectiveness of
Lipid-Mod…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Short-term alternatives
to psychiatric
rehospitalization (in
individuals not at
significant risk of harm … The most significant harm of an overly short LOS is having individuals
return to community settings … The
harm of forced treatment is mistrust of mental health professionals and
reduced willingness to … maleficence – making clinical
decisions that will provide one's patients with benefit and not with harm … postdischarge suicide rates…”
See comments relating to p. 24 line 43-49:
The most significant harm
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-surveillance-report.pdf
July 17, 2020 - Surveillance Report: Masks for Prevention of COVID-19 in Community and Healthcare Settings
Surveillance Report: July 17, 2020
Masks for Prevention of COVID-19 in
Community and Healthcare Settings:
Surveillance Report
Background
This surveillance report summarizes the search and update for the rapid review and l…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - Potential for social, economic, or psychological harm associated with use of
PCA3 assay for prostate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
June 05, 2024 - Enter the time frame over
which the subsequent harm
outcomes reported occur if
different than the … Text
Overdiagnosis Text
Comments on harm
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - 1
Comparative Effectiveness Review
Number 98
PCA3 Testing for the Diagnosis
and Management of Prostate Cancer
Executive Summary
Background
Cancer of the prostate is the second
most common cancer and the second
leading cause of cancer deaths in men
in the United States.1,2 Most patients
have slow-growing tu…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
April 28, 2015 - practices or the appropriate
intervention trajectory to obtain the best result with the
least amount of harm … We
agree that determining the
underlying cause of a harm (the
PPH or the intervention) is
challenging … We agree, but this is how the harm
was reported in the study.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
July 01, 2012 - CER # 19:
Comparative Effectiveness of Core Needle Biopsy and Open
Surgical Biopsy for Diagnosis of Breast Lesions
Original release date: December, 2009
Surveillance Report 1st Assessment: December, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings, 1st Assessment:
• For Key Question …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
January 01, 2013 - Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs
Future Research Needs Paper
Number 33
Biomarkers for Assessing
and Managing Iron
Deficiency Anemia in
Late-Stage Chronic
Kidney Disease: Future
Research Needs
Future Research Needs Paper
Numb…
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - AHRQ Slide Template 2009
Topic Refinement
Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Methods Guide for Effectiveness and Comparative Effectiveness Reviews
Topic Refinement
Systematic Review Process Overview
Systematic Review Process Overview
This slide illustrates the steps in the …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
April 01, 2010 - Source: www.effectivehealthcare.ahrq.gov
Published Online: March 02, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Comparative Effectiveness of Physical Therapy for Knee Pain Secondary to Osteoarthritis
I. Background and Objectives for the Systematic Review
Osteoarthritis (OA) is a…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
December 01, 2012 - textbook (e.g., UpToDate):
• Opposing findings (e.g., effective vs. ineffective) – A1
• Substantial harm … (e.g., the risk of harm outweighs the benefits) – A2
• A superior new treatment (e.g., new treatment